Review: Mortality in schizophrenia: a measurable clinical endpoint

Regional Differences in Five-Year Mortality After a First Episode of Schizophrenia in Finland

(2014) Marjo Kiviniemi et al.   PSYCHIATRIC SERVICES

Twenty-five year mortality of a community cohort with schizophrenia

(2010) Steve Brown et al.   BRITISH JOURNAL OF PSYCHIATRY

The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia11The views expressed in this article are the personal views of the author(s) and may not be understood or quoted as being made on behalf of or reflecting the position of the EMEA or one of its committees or working parties or the BfArM.

(2010) Maria Isaac et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine

(2010) Deanna L. Kelly et al.   JOURNAL OF CLINICAL PSYCHIATRY

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

(2010) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder

(2009) Thomas Munk Laursen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Smoking and mental illness: results from population surveys in Australia and the United States

(2009) David Lawrence et al.   BMC PUBLIC HEALTH

Mortality and tardive dyskinesia: long-term study using the US National Death Index

(2009) Charles E. Dean et al.   BRITISH JOURNAL OF PSYCHIATRY

Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare

(2009) Stephen Kisely et al.   BRITISH JOURNAL OF PSYCHIATRY

Cancer mortality in patients with schizophrenia

(2009) Eric Tran et al.   CANCER

Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia

(2009) Lone Baandrup et al.   JOURNAL OF CLINICAL PSYCHIATRY

Mortality Rates Among Patients With Schizophrenia and Tardive Dyskinesia

(2009) Siow-Ann Chong et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Completed suicide in schizophrenia: Evidence from a case-control study

(2009) Maurizio Pompili et al.   PSYCHIATRY RESEARCH

Psychosocial Treatments to Promote Functional Recovery in Schizophrenia

(2009) R. S. Kern et al.   SCHIZOPHRENIA BULLETIN

Influence of antipsychotics on mortality in schizophrenia: Systematic review

(2009) Stefan Weinmann et al.   SCHIZOPHRENIA RESEARCH

Suicide rate in schizophrenia in the Northern Finland 1966 Birth Cohort

(2009) Antti Alaräisänen et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis

(2008) V. S. Catts et al.   ACTA PSYCHIATRICA SCANDINAVICA

Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994–2003

(2008) Susanne Oksbjerg Dalton et al.   EUROPEAN JOURNAL OF CANCER

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia

(2008) Jari Haukka et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005

(2007) Rebecca M. Capasso et al.   SCHIZOPHRENIA RESEARCH